Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_assertion evidence source_evidence_literature NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_assertion SIO_000772 10866999 NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_assertion wasDerivedFrom befree-2016 NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_assertion wasGeneratedBy ECO_0000203 NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
- befree-2016 importedOn "2016-02-19" NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.